Urosepsis due to obstructive stones: Epidemiological data from a population-based study in Sweden [0.03%]
瑞典基于人群的研究中梗阻性结石引发尿路脓毒血症的流行病学数据
Hjalmar Svensson,Lars Grenabo,Klas Lindqvist et al.
Hjalmar Svensson et al.
Objective: The study's aim is to provide a population-based description of the incidence, epidemiology, and clinical course of urinary tract infection or sepsis caused by ureteric stone obstruction. Although being a life-...
Correction to 'computerized tomography-derived body composition metrics are associated with 24-h urine lithogenic parameters' [0.03%]
关于“基于计算机断层扫描的体组成参数与24小时尿结石生成参数相关”的更正通知
[This corrects the article DOI: 10.1002/bco2.70152.]. © 2026 The Author(s). BJUI Compass published by John Wiley & Sons Ltd on behalf of BJU Internation...
Published Erratum
BJUI compass. 2026 Feb 16;7(2):e20013. DOI:10.1002/bco2.70174 2026
Endoscopic management of ureteral injuries arising from gynecologic procedures [0.03%]
妇科手术引起的输尿管损伤的内镜治疗
Ari Luder,Asaf Shvero,Roey Mashiach et al.
Ari Luder et al.
Introduction: Ureteral injuries during gynecologic surgery are uncommon (0.1%-2.5%) but may result in significant morbidity, including strictures, hydronephrosis and the need for additional interventions. This study evalu...
Predictors of adherence to surveillance cystoscopy for patients with non-muscle invasive bladder cancer [0.03%]
非肌层浸润性膀胱癌患者的内镜监测依从性的预测因素分析
Katherina Y Chen,Marieke K Jones,Soutik Ghosal et al.
Katherina Y Chen et al.
Objective: To identify factors associated with decreased adherence to the national risk-stratified surveillance cystoscopy schedule for non-muscle invasive bladder cancer (NMIBC). ...
Effect of extending the oral administration period of 5-aminolevulinic acid on diagnostic accuracy and treatment outcomes for non-muscle-invasive bladder cancer [0.03%]
延长给予氨基叶酸口服给药时间对非肌层浸润性膀胱癌诊断准确性及治疗效果的影响
Hideo Fukuhara,Ryu Shigehisa,Shinkuro Yamamoto et al.
Hideo Fukuhara et al.
Objectives: To evaluate the treatment outcomes of 5-aminolevulinic acid hydrochloride (5-ALA) photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumour (TURBT) (ALA PDD-TURBT, hereinafter referred to...
Functional outcomes and toxicity following focal low-dose-rate brachytherapy for low-intermediate risk prostate cancer [0.03%]
低剂量率近距离放疗治疗前列腺癌的功能预后及毒性研究
Mohammadmehdi Adhami,Jeremy Cheng,Elliot Anderson et al.
Mohammadmehdi Adhami et al.
Objectives: We aim to prospectively evaluate functional outcomes and toxicity following focal low-dose-rate (LDR) brachytherapy for low-intermediate risk prostate cancer (PCa). ...
Oncological outcomes post focal low-dose-rate brachytherapy in low-intermediate risk prostate cancer [0.03%]
低中危前列腺癌局灶低剂量率组织间照射治疗的肿瘤学结局
Mohammadmehdi Adhami,Jeremy Cheng,Elliot Anderson et al.
Mohammadmehdi Adhami et al.
Objectives: To prospectively evaluate oncological control, pathological progression, and its predictors following focal low-dose-rate (LDR) brachytherapy for low-intermediate risk prostate cancer (PCa). ...
Streamlining urology cancer multidisciplinary team meetings: Implementation and outcomes [0.03%]
泌尿生殖系统肿瘤多学科综合治疗组实践与疗效评估
Hossein Arang,Adeyinka Pratt,Muhammed Rashim Parappan et al.
Hossein Arang et al.
Objectives: This work aimed to evaluate the implementation and impact of a pre-multidisciplinary team (MDT) triage model using Standards of Care (SoC) for streamlining in a urology cancer service. ...
Survival outcomes in prostate cancer patients treated at an Indian tertiary care centre [0.03%]
印度三级医疗中心治疗的前列腺癌患者的生存结果
Aswathy P,Sivaranjini Kannusamy,Amey Oak et al.
Aswathy P et al.
Background: Prostate cancer is an emerging public health concern in India, with rising incidence and varying survival outcomes. This study aimed to evaluate 5-year overall survival and identify prognostic factors among pr...
AI-enhanced micro-ultrasound improves detection of clinically significant prostate cancer at biopsy [0.03%]
人工智能辅助微型超声波提高活检时显著前列腺癌的检测率
Muhammad Imran,Wayne G Brisbane,Li-Ming Su et al.
Muhammad Imran et al.
Objective: This study aimed to evaluate the diagnostic accuracy of artificial intelligence (AI)-enhanced micro-ultrasound (micro-US) for detecting clinically significant prostate cancer (csPCa) in men referred for prostat...